Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Oxaliplatin × Clear all

Sponsor

Conditions

Colorectal Neoplasms 85 Stomach Neoplasms 47 Rectal Neoplasms 46 Pancreatic Neoplasms 37 Colonic Neoplasms 31 Esophageal Neoplasms 28 Neoplasm Metastasis 25 Neoplasms 21 Adenocarcinoma Of Esophagus 17 Adenocarcinoma 9 Lymphoma, Large B-Cell, Diffuse 6 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Non-Small-Cell Lung 6 Liver Neoplasms 5 Gallbladder Neoplasms 5 Recurrence 4 Ovarian Neoplasms 4 Lymphoma, Non-Hodgkin 4 Head and Neck Neoplasms 4 Biliary Tract Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Gastrointestinal Neoplasms 3 Fallopian Tube Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Bile Duct Neoplasms 3 Pancreatic Adenocarcinoma 2 Neuroendocrine Tumors 2 Lymphoma 2

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡